Lomitapide mesylate Catalog No.:M10368-10 2λ⁵-oxazaphosphinan-2-one

2λ⁵-oxazaphosphinan-2-one

Formula: C6H11O7P

5-100 mg/kg once per day in combination with rituximab and Bendamustine

which occurs in necrosis

in cells exposed to submicromolar drug in a manner that depends on covalent modification of the conserved cysteine residue

Lomitapide mesylate Catalog No.:M10368-10 2λ⁵-oxazaphosphinan-2-oneLomitapide is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozygous familial hypercholesterolemia. Lomitapide is an orally active inhibitor of microsomal triglyceride transfer protein that is indicated as an adjunct to a low fat diet and other lipid lowering treatments, including LDL apheresis where available for the reduction of LDL C, total cholesterol, apolipoprotein B, and non high density lipoprotein cholesterol in adult